In a joint poster with Bachem, one of the world’s leading CDMOs in siRNA manufacturing, Codexis will feature data demonstrating the superiority of its double-stranded RNA ligase variants ...
The mystery of why life uses molecules with specific orientations has deepened with a discovery that RNA—a key molecule ...
Appointments may be made in advance by contacting the business development team. Ribonucleic acid (RNA) as a therapeutic modality has gained tremendous traction in recent years with the growing ...
In a joint poster with Bachem, one of the world’s leading CDMOs in siRNA manufacturing, Codexis will feature data demonstrating the superiority of its double-stranded RNA ligase ...
REDWOOD CITY, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today ...
Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback